查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全基因组测序市场 - 2018-2028 年全球行业规模、份额、趋势、竞争、机会及预测。按测序类型、按产品类型、按应用、按最终用户、按地区和竞争情况划分
市场调查报告书
商品编码
1309867

全基因组测序市场 - 2018-2028 年全球行业规模、份额、趋势、竞争、机会及预测。按测序类型、按产品类型、按应用、按最终用户、按地区和竞争情况划分

Whole Genome Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028. Segmented By Sequencing Type, By Product Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

在 2024-2028 年的预测期内，全基因组测序市场预计将以惊人的复合年增长率增长。这可归因于以下因素

技术不断进步

NGS 仪器技术的不断进步和测序技术的更新将进一步推动测序市场在预测期内的增长。此外，与毛细管测序或基于 PCR 的方法不同，下一代测序（NGS）具有复用功能，使微生物研究人员能够对数百种生物进行测序。基于 NGS 的微生物基因组测序不仅省时高效，而且简化了工作流程，不像老式技术那样依赖于耗时的克隆阶段。此外，可能会被忽视的低频变异和基因组重排，使用现有技术发现成本太高，而使用 NGS（下一代测序）则可以发现。此外，当今时代的群体级 WES（全外显子组测序）数据生成量也在增加。全外显子组测序（WES）是测序领域的一项成功应用，孟德尔表型、米勒氏病等疾病的基因的发现证明了这一点。全外显子测序比全基因组测序更有用，因为大多数已知的致病突变都发生在外显子中，市场需求量很大，因此预计未来将推动市场增长。

疾病诊断需求不断增长

全基因组测序在疾病诊断方面的临床应用需求日益增长，在鉴定基因组片段突变以分离基因变异或突变方面具有重要意义。此外，微生物全基因组重测序等技术涉及对细菌、病毒或其他微生物的整个基因组进行测序，并将测序结果与已知参照物的序列进行比较，因此有助于疾病诊断。因此，这种微生物基因组测序是微生物鉴定的重要工具。此外，全基因组测序技术还可用于识别生物体内碱基的排列顺序，从而生成精确的 DNA 指纹，有助于将病例联系起来，快速检测出疾病的爆发或缺陷，因此在传染病诊断方面具有重要意义，从而促进预测期内的市场增长。

基因组测绘应用增加

政府项目对基因组测绘的需求不断增加，因为与疾病诊断和研究有关的研发工作日益增多，以改善癌症、突变性疾病和其他疾病的治疗等。此外，不同国家和地区的政府正在对数百万个基因组进行测序，以促进研究，发现更好的方法来识别和治疗癌症、不常见疾病和其他疾病。例如，欧洲政府正在通过法国的 "2025 年法国基因组医学计划 "和英国的 "10 万基因组计划 "等项目，努力改善该地区的大规模基因组数据。这些倡议促进了 NGS 下一代测序（NGS）信息学服务在该地区的发展。例如，2022 年 11 月，斯坦福医科大学的科学家利用纳米孔基因组测序、人工智能和云计算，在不到 5 个小时的时间内完成了一名患者的全基因组测序。

最新进展

2021 年 11 月，Illumina 和基因联盟宣布了一项价值 1.2 亿美元的全球计划 - iHope 基因健康计划。该计划旨在为全球各种受遗传疾病影响的患者提供全基因组测序（WGS）服务。

此外，2020 年，领先企业 QIAGEN 收购了 NeuMoDx Molecular，巩固了其在自动化分子检测市场的地位。现在，该公司将基于 PCR 检测技术的中高通量 NeuMoDx 自动化解决方案作为其最新产品组合的新组成部分。

可定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。报告可提供以下定制选项：

公司信息

  • 其他市场参与者（最多五家）的详细分析和概况。

目录

第 1 章：服务概述

  • 市场定义
  • 市场范围
    • 市场覆盖范围
    • 研究年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目标
  • 基准方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量与验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概述
  • 主要市场细分概述
  • 主要市场参与者概述
  • 主要地区/国家概述
  • 市场驱动因素、挑战和趋势概述

第4章：客户之声

第5章：全基因组测序市场前景。

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 按测序类型（大型全基因组测序和小型基因组测序）
    • 按产品类型（仪器、试剂盒和服务）
    • 按应用（诊断、药物发现与开发、个性化医疗及其他）
    • 按最终用户（医院和诊所、制药和生物技术公司及其他）
    • 按公司（2022 年）
    • 按地区
  • 市场地图
    • 按测序类型
    • 按产品类型
    • 按应用
    • 按最终用户
    • 按地区

第6章：亚太地区全基因组测序市场前景

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 测序类型
    • 产品类型
    • 应用
    • 终端用户
    • 按国家分类
  • 亚太地区：国家分析
    • 中国 .
    • 印度 .
    • 印度 .
    • 日本
    • 澳大利亚

第 7 章 : 欧洲全基因组测序市场前景

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 测序类型
    • 产品类型
    • 应用
    • 终端用户
    • 按国家分类
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章：北美全基因组测序市场前景。

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 测序类型
    • 产品类型
    • 应用
    • 终端用户
    • 按国家分类
  • 北美洲：国家分析
    • 美国全基因组测序市场前景
      • 市场规模与预测
        • 按价值
      • 市场份额与预测
        • 测序类型
        • 产品类型
        • 应用
        • 终端用户
    • 墨西哥全基因组测序市场前景
      • 市场规模与预测
        • 按价值
      • 市场份额与预测
        • 测序类型
        • 产品类型
        • 应用
        • 终端用户
    • 加拿大全基因组测序市场前景
      • 市场规模与预测
        • 按价值
      • 市场份额与预测
        • 测序类型
        • 产品类型
        • 应用
        • 终端用户

第 9 章 : 南美洲全基因组测序市场前景

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 测序类型
    • 产品类型
    • 应用
    • 终端用户
    • 按国家分类
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章 : 中东和非洲全基因组测序市场前景

  • 市场规模与预测
    • 按价值
  • 市场份额与预测
    • 测序类型
    • 产品类型
    • 应用
    • 终端用户
    • 按国家
  • 中东和非洲：国家分析
    • 南非 全基因组测序
    • 沙特阿拉伯全基因组测序
    • 阿联酋 全基因组测序
    • 科威特全基因组测序

第 11 章 ：市场动态

  • 驱动因素
  • 挑战

第 12 章 ：市场趋势与发展

  • 近期动态
  • 合併与收购
  • 产品开发

第 13 章 ：竞争格局

  • 业务概述
  • 公司概况
  • 产品与服务
  • 财务状况（上市公司）
  • 近期发展
  • SWOT 分析
    • GE Healthcare, Inc.
    • Illumina, Inc.
    • QIAGEN N.V.
    • Thermo Fisher Scientific
    • Agilent Technologies
    • 10 x Genomics
    • BGI
    • Oxford Nanopore
    • Nebula Genomics
    • Veritas Genetics.

第 14 章：战略建议

简介目录
Product Code: 14973

Whole Genome Sequencing Market is expected to grow with an impressive CAGR in the forecast period 2024-2028. This can be attributed to factors such as

Whole Genome Sequencing Market (WGS) is a widely used application included in genome, microbial resequencing, and genome sequencing. It is expected to increase significantly with the growing research in genomics. Additionally, a rise in the usage of this technology against COVID-19 in sequencing the data of the COVID-19 virus is expected to drive market growth.

Whole Genome Sequencing Market (WGS) technology can deliver quick results and high-quality data. It can be used to locate, monitor, and address disease outbreaks in a region. WGS is shown to be most useful in research and rarely in therapeutic treatments.

The mapping of novel organisms' genomes, the completion of the genomes of already-known organisms, or the comparison of genomes from other samples all benefit from microbial whole-genome sequencing. To create reliable reference genomes, microbial identification, and other comparative genomic investigations, it is required to sequence the full bacterial, viral, and other microbial genomes.

Growing Technological Advancement

Increasing technological advancement in NGS instruments and update in technology utilized in Sequencing techniques are adding to further drive the sequencing market growth in the forecast period. Moreover, with its multiplexing feature, next-generation sequencing (NGS) enables microbiology researchers to sequence hundreds of organisms, unlike capillary sequencing or PCR-based methods. NGS-based microbial genome sequencing is time efficient and streamlines the workflow, and does not rely on time-consuming cloning stages like older techniques. Additionally, low-frequency variations and genomic rearrangements that might be overlooked are too expensive to find using current techniques that can be found using NGS (Next Generation Sequencing). Also, population-level WES (whole exome sequencing) data generation has increased in today's time. Whole exome sequencing (WES) is a successful application in the field of sequencing and is proved by the discovery of the genes for the conditions such as Mendelian phenotypes, Miller's disease, and other diseases. Whole exome sequencing is more useful than whole genome sequencing since the majority of known disease-causing mutations take place in exons and are in high demand in the market and thus anticipated to propel the market growth in the future.

Growing Demand in Disease Diagnosis

Whole genome sequencing has an increased demand in clinical applications regarding disease diagnosis and has significant importance in the identification of a mutation in a genome segment for isolating a variant or mutation in a gene. Moreover, techniques such as Microbial whole-genome resequencing involve the sequencing of the entire genome of a bacteria, virus, or other microbe and comparing the sequence to that of a known reference and thus is helpful in disease diagnosis. This microbial genome sequencing is thus an important tool for microbial identification. Additionally, the whole genome sequencing technique is used for identifying the order of bases in the organism and is thus utilized to produce a precise DNA fingerprint and thus can aid in linking the cases allowing the eruption or defect to be detected quickly and, thus, is significant in infectious disease diagnosis to bolster the market growth in the forecast period.

Increased Application in Genome Mapping

The rising demand for genome mapping in government projects for the rising research and development related to disease diagnosis and research for improved treatment in cancer, mutated disorders, and other diseases, etc. Furthermore, governments of distinct countries and regions are sequencing millions of genomes to progress research and discover better ways to identify and cure cancer, uncommon disorders, and other ailments. For instance, the European government is undertaking efforts to improve the region's large-scale genomic data with projects such as France's French Plan for Genomic Medicine 2025 and, similarly, the United Kingdom's 100,000 Genomes Project. These initiatives have resulted in the growth of NGS's Next-generation sequencing (NGS) informatics services in the region. For instance, in November 2022, using Nanopore Genome Sequencing, AI, and Cloud Computing, scientists at Stanford Medicine University sequenced a patient's whole genome in under five hours.

Recent Developments

In November 2021, Illumina and Genetic Alliance announced a USD 120 million global initiative-the iHope Genetic Health program. This initiative aims to offer Whole Genome Sequencing (WGS) access to various patients impacted by genetic disorders globally.

Also, In 2020, a leading company QIAGEN acquired NeuMoDx Molecular and secured its position in the market in automated molecular testing. The company now includes medium- and high-throughput NeuMoDx automation solutions based on PCR testing technology as a new component of its updated product portfolio.

Market Segmentation

The whole Genome Sequencing Market is segmented based on the sequencing type, product type, application, end-user, and region. Based on sequencing type, the market is segmented into large whole-genome sequencing and small-genome sequencing. Based on product type, the market is segmented into instruments, kits, and services. Based on application, the market is segmented into diagnostics, drug discovery and development, personalized medicine, and others. Based on end users, the market is further fragmented into hospitals and clinics, pharmaceutical and biotechnology companies, and others. Based on the region, the market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Market Players

GE Healthcare, Inc., Illumina, Inc., QIAGEN N.V., Thermo Fisher Scientific, Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics, etc.., are some of the major players operating in the global Whole Genome Sequencing Market.

Report Scope

In this report, Whole Genome Sequencing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Whole Genome Sequencing Market, By Sequencing Type:

  • Large Whole-Genome Sequencing
  • Small Genome Sequencing

Whole Genome Sequencing Market, By Product Type:

  • Instrument
  • Kits
  • Service

Whole Genome Sequencing Market, By Application:

  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • Others

Whole Genome Sequencing Market, By End User:

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Whole Genome Sequencing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Whole Genome Sequencing Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered.
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Whole Genome Sequencing Market Outlook.

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sequencing Type (Large Whole-Genome Sequencing and Small Genome Sequencing)
    • 5.2.2. By Product Type (Instrument, Kits, and Service)
    • 5.2.3. By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others)
    • 5.2.4. By End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others)
    • 5.2.5. By Company (2022)
    • 5.2.6. By Region
  • 5.3. Market Map
    • 5.3.1. By Sequencing Type
    • 5.3.2. By Product Type
    • 5.3.3. By Application
    • 5.3.4. By End User
    • 5.3.5. By Region

6. Asia-Pacific Whole Genome Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. Sequencing Type
    • 6.2.2. Product Type
    • 6.2.3. Application
    • 6.2.4. End User
    • 6.2.5. By Country
  • 6.3. Asia-Pacific: Country Analysis
    • 6.3.1. China Whole Genome Sequencing Market Outlook.
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. Sequencing Type
        • 6.3.1.2.2. Product Type
        • 6.3.1.2.3. Application
        • 6.3.1.2.4. End User
    • 6.3.2. India Whole Genome Sequencing Market Outlook.
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. Sequencing Type
        • 6.3.2.2.2. Product Type
        • 6.3.2.2.3. Application
        • 6.3.2.2.4. End User
    • 6.3.3. South Korea Whole Genome Sequencing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. Sequencing Type
        • 6.3.3.2.2. Product Type
        • 6.3.3.2.3. Application
        • 6.3.3.2.4. End User
    • 6.3.4. Japan Whole Genome Sequencing Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. Sequencing Type
        • 6.3.4.2.2. Product Type
        • 6.3.4.2.3. Application
        • 6.3.4.2.4. End User
    • 6.3.5. Australia Whole Genome Sequencing Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. Sequencing Type
        • 6.3.5.2.2. Product Type
        • 6.3.5.2.3. Application
        • 6.3.5.2.4. End User

7. Europe Whole Genome Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. Sequencing Type
    • 7.2.2. Product Type
    • 7.2.3. Application
    • 7.2.4. End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Whole Genome Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. Sequencing Type
        • 7.3.1.2.2. Product Type
        • 7.3.1.2.3. Application
        • 7.3.1.2.4. End User
    • 7.3.2. Germany Whole Genome Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. Sequencing Type
        • 7.3.2.2.2. Product Type
        • 7.3.2.2.3. Application
        • 7.3.2.2.4. End User
    • 7.3.3. United Kingdom Whole Genome Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. Sequencing Type
        • 7.3.3.2.2. Product Type
        • 7.3.3.2.3. Application
        • 7.3.3.2.4. End User
    • 7.3.4. Italy Whole Genome Sequencing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. Sequencing Type
        • 7.3.4.2.2. Product Type
        • 7.3.4.2.3. Application
        • 7.3.4.2.4. End User
    • 7.3.5. Spain Whole Genome Sequencing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. Sequencing Type
        • 7.3.5.2.2. Product Type
        • 7.3.5.2.3. Application
        • 7.3.5.2.4. End User

8. North America Whole Genome Sequencing Market Outlook.

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. Sequencing Type
    • 8.2.2. Product Type
    • 8.2.3. Application
    • 8.2.4. End User
    • 8.2.5. By Country
  • 8.3. North America: Country Analysis
    • 8.3.1. United States Whole Genome Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. Sequencing Type
        • 8.3.1.2.2. Product Type
        • 8.3.1.2.3. Application
        • 8.3.1.2.4. End User
    • 8.3.2. Mexico Whole Genome Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. Sequencing Type
        • 8.3.2.2.2. Product Type
        • 8.3.2.2.3. Application
        • 8.3.2.2.4. End User
    • 8.3.3. Canada Whole Genome Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. Sequencing Type
        • 8.3.3.2.2. Product Type
        • 8.3.3.2.3. Application
        • 8.3.3.2.4. End User

9. South America Whole Genome Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. Sequencing Type
    • 9.2.2. Product Type
    • 9.2.3. Application
    • 9.2.4. End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Whole Genome Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. Sequencing Type
        • 9.3.1.2.2. Product Type
        • 9.3.1.2.3. Application
        • 9.3.1.2.4. End User
    • 9.3.2. Argentina Whole Genome Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. Sequencing Type
        • 9.3.2.2.2. Product Type
        • 9.3.2.2.3. Application
        • 9.3.2.2.4. End User
    • 9.3.3. Colombia Whole Genome Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. Sequencing Type
        • 9.3.3.2.2. Product Type
        • 9.3.3.2.3. Application
        • 9.3.3.2.4. End User

10. Middle East and Africa Whole Genome Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. Sequencing Type
    • 10.2.2. Product Type
    • 10.2.3. Application
    • 10.2.4. End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Whole Genome Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. Sequencing Type
        • 10.3.1.2.2. Product Type
        • 10.3.1.2.3. Application
        • 10.3.1.2.4. End User
    • 10.3.2. Saudi Arabia Whole Genome Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. Sequencing Type
        • 10.3.2.2.2. Product Type
        • 10.3.2.2.3. Application
        • 10.3.2.2.4. End User
    • 10.3.3. UAE Whole Genome Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. Sequencing Type
        • 10.3.3.2.2. Product Type
        • 10.3.3.2.3. Application
        • 10.3.3.2.4. End User
    • 10.3.4. Kuwait Whole Genome Sequencing Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. Sequencing Type
        • 10.3.4.2.2. Product Type
        • 10.3.4.2.3. Application
        • 10.3.4.2.4. End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Developments

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Company Snapshot
  • 13.3. Products & Services
  • 13.4. Financials (In case of listed companies)
  • 13.5. Recent Developments
  • 13.6. SWOT Analysis
    • 13.6.1. GE Healthcare, Inc.
    • 13.6.2. Illumina, Inc.
    • 13.6.3. QIAGEN N.V.
    • 13.6.4. Thermo Fisher Scientific
    • 13.6.5. Agilent Technologies
    • 13.6.6. 10 x Genomics
    • 13.6.7. BGI
    • 13.6.8. Oxford Nanopore
    • 13.6.9. Nebula Genomics
    • 13.6.10. Veritas Genetics.

14. Strategic Recommendations